Anti-Infectives

News Anti-Infectives

• Ferrer initiates phase III clinical studies for novel antibacterial compound, ozenoxacin, in development as a topical treatment for impetigo and other infectious dermatological ...

  Ferrer announced that it has received approval to initiate phase III clinical trials of ozenoxacin formulated as a topical treatment for infectious dermatological conditions. The first patients are expected to enter the trials in February 2012 and the studies are scheduled to complete in the first q more

• DSM and Sinochem Group establish global anti-infectives joint venture

  Royal DSM announced that it has established the 50/50 global joint venture for its business group DSM Anti-Infectives with Sinochem Group. All applicable regulatory approvals and customary clearances from competition authorities have been received. The agreement to form the joint venture was announc more

• AbD Serotec Signs Agreement with Dana-Farber Cancer Institute for Anti-Infective Research

  MorphoSys AG announced that its AbD Serotec unit entered a research and supply agreement with the Department of Cancer Immunology and AIDS at Dana-Farber Cancer Institute (DFCI) in Boston. Dana-Farber is engaged in research activities within a project funded by the Defense Advanced Research Projects more

Publications Anti-Infectives

• Syntetic Oligosacharides Clinical Application in Cancer Therapy

  Abstract: It is well established that glucans enhance the efficacy of anti-cancer and anti-infection immunotheraphy, both in clinical and experimental conditions. However, the considerable variations among batches of natural glucan in molecular weight, branching frequency, as well as linkag more

• Multiple Targeted Drugs Carrying Biodegradable Membrane Barrier: Anti-Adhesion, Hemostasis, and Anti-Infection

  A multiple targeted drug carrying bilayer membrane for preventing an abdominal adhesion is prepared by electrospinning. Two bioactive drugs were successfully incorporated into this bilayer membrane and can be independently released from nanofibrous scaffolds without losing structural integrity and f more

• Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives

  With the increased emergence of anti-infective resistance in recent years, much focus has recently been drawn to the development of new anti-infectives and the optimization of treatment regimens and combination therapies for established antimicrobials. In this context, the field of pharmacometrics u more

Market studies Anti-Infectives

• Veterinary Health Markets

  Veterinary health products, including veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs), have transformed the health and welfare of livestock and companion animals worldwide. The range and complexity of animal health products continues to expand, encompassing anti-infective more

• Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Financial and Strategic SWOT Analysis Review

  Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) is a public share holding company engaged in the manufacture and sale of bulk drugs. The company is principally focused in providing drugs used in more

• K-V Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review

  K-V Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review Summary K-V Pharmaceutical Company (KV Pharmaceutical) is a specialty pharmaceutical company. It undertakes the development, manufacture and marketing of branded pharmaceuticals in various dosage forms such as solids, more

Websites Anti-Infectives